Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, The Miriam Hospital Weight Control and Diabetes Research Center, Providence, Rhode Island 02903, USA.
Surg Obes Relat Dis. 2011 Jan-Feb;7(1):1-7. doi: 10.1016/j.soard.2010.05.015. Epub 2010 Jun 4.
We have previously reported that most women seeking bariatric surgery have had female sexual dysfunction (FSD) as defined by the validated Female Sexual Function Index (FSFI). The present study examined whether FSD resolves after bariatric surgery.
A total of 54 reportedly sexually active women (43.3 ± 9.5 years) completed the FSFI preoperatively and 6 months postoperatively after a mean percentage of excess weight loss of 42.3% (laparoscopic adjustable gastric banding [n = 38], percentage of excess weight loss, 34.6% ± 15.7%; Roux-en-Y gastric bypass [n = 16], percentage of excess weight loss 60.0% ± 21.2%). The FSFI assesses sexual function across 6 domains, with higher scores indicating better sexual function. The summing of these scores yields a FSFI total score (range 2-36, with a score of ≤ 26.55 indicating FSD).
Before surgery, 34 women (63%) had scores indicative of FSD. By 6 months postoperatively, the FSD had resolved in 23 (68%) of these 34 women, and only 1 woman had developed FSD postoperatively. In the entire sample, significant (P < .05) improvements occurred from before to after surgery on all FSFI domains. The FSFI total scores improved after laparoscopic adjustable gastric banding (from 24.2 ± 5.9 to 29.1 ± 4.1, P < .001) and Roux-en-Y gastric bypass (from 23.7 ± 7.7 to 30.0 ± 4.7, P < .001). In regression analyses, being married, younger age, and worse preoperative sexual function were related to greater sexual function improvements. Postoperatively, the participants' FSFI total scores were indistinguishable from those of published normative controls (29.4 ± 4.3 versus 30.5 ± 5.3, P = .18).
FSD resolved in a large percentage of women after bariatric surgery. Sexual functioning in the entire sample improved to levels consistent with those of normative controls. This improvement in sexual function did not depend on surgery type or weight loss amount and appears to be an additional benefit for women undergoing bariatric surgery.
我们之前报道过，大多数寻求减肥手术的女性都有女性性功能障碍（FSD），这是根据经过验证的女性性功能指数（FSFI）定义的。本研究旨在探讨减肥手术后 FSD 是否得到解决。
共有 54 名据称有性生活的女性（43.3±9.5 岁）在接受腹腔镜可调胃带术（n=38，超重减轻百分比为 34.6%±15.7%）或 Roux-en-Y 胃旁路术（n=16，超重减轻百分比为 60.0%±21.2%）减肥手术后 6 个月，完成了 FSFI 术前和术后评估。FSFI 评估了 6 个领域的性功能，得分越高表示性功能越好。这些分数的总和得出 FSFI 总分（范围 2-36，得分≤26.55 表示 FSD）。
术前，34 名女性（63%）的得分表明存在 FSD。术后 6 个月时，这 34 名女性中有 23 名（68%）FSD 得到解决，只有 1 名女性术后出现 FSD。在整个样本中，所有 FSFI 领域在术前到术后均有显著（P<.05）改善。腹腔镜可调胃带术（从 24.2±5.9 到 29.1±4.1，P<.001）和 Roux-en-Y 胃旁路术（从 23.7±7.7 到 30.0±4.7，P<.001）后 FSFI 总分均有改善。回归分析表明，已婚、年龄较小和术前性功能较差与性功能改善程度较大相关。术后，参与者的 FSFI 总分与已发表的正常对照无显著差异（29.4±4.3 与 30.5±5.3，P=.18）。
减肥手术后，大多数女性的 FSD 得到解决。整个样本的性功能改善到与正常对照一致的水平。性功能的这种改善不依赖于手术类型或减重幅度，似乎是女性接受减肥手术的另一个额外益处。
